There are several effective systemic treatments for psoriasis, but deciding which patients may benefit can be a challenge. This is especially true when faced with a group that may not be included in a clinical trial, such as pregnant patients, patients with HIV or hepatitis, and pediatric patients. A new article in a continuing education …
Getting enough sleep is essential to maintaining optimal health and health–related quality of life (HRQoL). The physical symptoms of psoriasis may affect sleep and by association impair quality of life. Poor sleep is a risk factor for depression, cardiovascular disease, hypertension and diabetes. Insomnia, the most common sleep disorder, is defined as difficulty falling asleep …
Liver cirrhosis is a concern for patients with psoriasis that are treated long-term with methotrexate (MTX). Previous studies have shown that patients with psoriasis who received long-term MTX were more likely to develop severe liver fibrosis or cirrhosis. Based on this data, a recent study from Taiwan sought to explore the effects of MTX on …
Psoriasis has many effects on quality of life that extend beyond day-to-day management of the skin condition. A recent study sought to determine whether patients with psoriasis have a higher risk of sexual dysfunction (SD) or erectile dysfunction (ED) compared with the healthy population, and to review the available scientific evidence regarding the associations between …
At the first product theater on day 3 of the 16th Annual Fall Dermatology Conference, Dr. Firas Hougeir shared his extensive knowledge and experience in the treatment of patients with psoriasis with his lecture entitled Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis. Dr. Hougeir started his lecture …
On Friday November 2, the second full day of SDPA’s 16th Annual Fall Dermatology Conference Dr. Misha Rosenbach spoke about What’s New in Biologics. Many of the topics he discussed included off label use since indications are still limited. His specialty is granulomatous and neutrophilic diseases and he has used biologic therapy for such conditions …